|
|
| Hemofil-M (human plasma derived coagulation factor VIII) / Takeda (0 Trials) |
|
| hemophilia A cell therapy / Sernova (0 Trials) |
|
| hemophilia A lentiviral gene transfer therapy / Ospedale San Raffaele, Sanofi (0 Trials) |
|
| hemophilia A therapeutic / Recursion Pharma (0 Trials) |
|
| hemophilia A therapeutic / Lambdagen Therap (0 Trials) |
|
| hemophilia A therapeutic / Generation Bio (0 Trials) |
|
| hemophilia A therapeutic / Precision BioSci (0 Trials) |
|
| hemophilia A therapy / Immusoft (0 Trials) |
|
| hemophilia B lentiviral gene transfer therapy / Ospedale San Raffaele, Sanofi (0 Trials) |
|
| Hemophilia specific therapeutic antibody / Initium Therap (0 Trials) |
|
| hemophilia therapy / 3B Pharma, Takeda (0 Trials) |
|
| Hemoraas (plasma-derived human coagulation factor VIII) / Tonrol Biopharm (0 Trials) |
|
| HemoRel A (anti - hemophilic factor) / Reliance Life Sci (0 Trials) |
|
| henagliflozin/metformin (HR20033) / Jiangsu Hengrui Pharma (0 Trials) |
|
| henagliflozin/metformin/retagliptin (HR20031) / Jiangsu Hengrui Pharma (0 Trials) |
|
| henatinib / Shanghai Inst. of Materia Medica, Jiangsu Hengrui Pharma (0 Trials) |
|
| Hengmu (tenofovir amibufenamide) / Jiangsu Hansoh Pharma (0 Trials) |
|
| Hengqu (hetrombopag) / Jiangsu Hengrui Pharma (0 Trials) |
|
| Henletor (torsemide) / Orchid (10 Trials) |
|
| Hensify (crystalline hafnium oxide) / Nanobiotix, J&J (11 Trials) |
|
| Hepabig (hepatitis b immunoglobulin (human)) / VHB Life Sci, Green Cross Cell (0 Trials) |
|
| Hepabig-gene (lenvervimab) / GC Biopharma (1 Trials) |
|
| Hepacid (pegargiminase) / Polaris Pharma (10 Trials) |
|
| Hepadvax (hepatitis B vaccine) / Vaxine (0 Trials) |
|
| HepaGam B (hepatitis B immune globulin intravenous (human)) / Kamada (0 Trials) |
|
| hepalatide (L47) / Shanghai HEP Pharma (0 Trials) |
|
| heparin / Ockham Biotech (0 Trials) |
|
| heparin sodium (VR496) / Vectura (2 Trials) |
|
| heparin sodium injection / Generic mfg. (37 Trials) |
|
| heparin-derived oligosaccharide (OPK-0018) / OPKO Health (0 Trials) |
|
| HepaStem (heterologous human adult liver-derived mesenchymal stem cells) / Cellaion (3 Trials) |
|
| hepatitis B adjuvanted vaccine (HBAI20) / CyTuVax (0 Trials) |
|
| Hepatitis B Immunoglobulin -P (human hepatitis B immunoglobulin) / CSL Behring (0 Trials) |
|
| hepatitis B virus ribonuclease H inhibitor / Casterbridge Pharma (0 Trials) |
|
| Hepatocellular Carcinoma therapeutic / Saronic Biotech (0 Trials) |
|
| Hepaton (thiazolidine) / SEDICO (0 Trials) |
|
| Hepatoren (ifetroban) / Cumberland (0 Trials) |
|
| Hepatothera (human anti-HBs immunoglobulin) / Meiji Seika (0 Trials) |
|
| Hepavac (IMA970A) / Immatics, CureVac (0 Trials) |
|
| Hepavir B (pradefovir) / Bausch Health (1 Trials) |
|
| Hepbarna (BB-HB-331) / Benitec BioPharma (0 Trials) |
|
| HepBQuin (human hepatitis B immunoglobulin) / Sanquin (0 Trials) |
|
| Hepcludex (bulevirtide) / Gilead (1 Trials) |
|
| hepenofovir / Xi’an XinTong Pharma (0 Trials) |
|
| Hepko-V5 (hepcortespenlisimut-L) / Immune Network (0 Trials) |
|
| Heplisav-B (hepatitis B vaccine (recombinant), adjuvanted) / Dynavax (6 Trials) |
|
| Hepta (epoetin alfa biosimilar) / Roemmers (0 Trials) |
|
| HepTcell (FP-02.2) / Altimmune (0 Trials) |
|
| HER-096 / Herantis (0 Trials) |
|
| HER-2 pulsed DC1 / ImmunoRestoration (0 Trials) |
|
| HER-2/neu peptide vaccine / National Cancer Institute - Bethesda (2 Trials) |
|
| Her-VAXX / Pevion, Imugene (2 Trials) |
|
| HER1-VSSP vaccine / Center of Molecular Immunology (0 Trials) |
|
| HER2 affitoxin / National Cancer Institute (0 Trials) |
|
| HER2 exon 20 inhibitor / Boehringer Ingelheim (0 Trials) |
|
| HER2 inhibitor / Cylene (0 Trials) |
|
| HER2 mAb / LFB SA (0 Trials) |
|
| HER2 t-haNK / ImmunityBio (0 Trials) |
|
| HER2 Targeted Topoisomerase 1 CDC / Elucida Oncology (0 Trials) |
|
| HER2 Tumor Vaccine / Bengbu Medical College (0 Trials) |
|
| HER2 vaccine / International Cancer Lab (0 Trials) |
|
| Her2 XmAb / Roche, Xencor (0 Trials) |
|
| HER2 Z00342 / Affibody (0 Trials) |
|
| HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, B7-H3 targeting CAR-TILs / Zhaotai InVivo Biomedicine (0 Trials) |
|
| HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, B7-H3 targeting TILs / Zhaotai InVivo Biomedicine (0 Trials) |
|
| HER2-MMAE / Spirea (0 Trials) |
|
| HER2-SADA / Y-mAbs Therap, Memorial Sloan-Kettering Cancer Center, Massachusetts Institute of Technology (0 Trials) |
|
| HER2-Specific CAR T / Cellevolve Bio, Seattle Children’s Therapeutics (0 Trials) |
|
| HER2xCD28 bispecific TCE POWERbody / Adagene (0 Trials) |
|
| HERA OX40L / Apogenix (0 Trials) |
|
| HERA-4-1BBL / Apogenix (0 Trials) |
|
| HERA-CD27L / Apogenix (0 Trials) |
|
| HERA-CD40L / Apogenix (0 Trials) |
|
| HERA-GITRL / Apogenix (0 Trials) |
|
| HERA-LIGHT / Apogenix (0 Trials) |
|
| Herceptin (trastuzumab) / Roche (464 Trials) |
|
| Herceptin Hylecta (trastuzumab/hyaluronidase-oysk) / Roche, Halozyme (9 Trials) |
|
| hermodulin (RBLX-200) / Servier (0 Trials) |
|
| Hernicore (condoliase) / Seikagaku, Ferring (1 Trials) |
|
| Herpes varicella zoster therapeutic / XBiotech (0 Trials) |
|
| Herpes Zoster therapeutic / Shulov Institute for Science (0 Trials) |
|
| HerpV / Agenus (0 Trials) |
|
| hersintuzumab / Tehran University of Medical Sciences (0 Trials) |
|
| HERtiCAD (trastuzumab biosimilar) / Biocad (0 Trials) |
|
| HERTUZab (trastuzumab biosimilar) / Clonz Biotech (0 Trials) |
|
| HERV targeted CAR-T therapy for RCC / Adagene, National Heart, Lung, and Blood Institute (0 Trials) |
|
| Hervelous (trastuzumab biosimilar) / Hanwha Solutions, Alvogen, Prestige BioPharma, Mundipharma, Dr. Reddy’s (1 Trials) |
|
| Hervlysis (genetically engineered oncolytic virus therapy) / CZ BioMed (0 Trials) |
|
| Hervycta (trastuzumab biosimilar) / Dr. Reddy’s, Intas (0 Trials) |
|
| Herwenda (trastuzumab biosimilar) / EirGenix, Sandoz (1 Trials) |
|
| Herzuma (trastuzumab-pkrb) / Nippon Kayaku, Mundipharma, Celltrion, Teva (12 Trials) |
|
| Hetlioz (tasimelteon) / Vanda (5 Trials) |
|
| Hex-hA20 / Gilead (0 Trials) |
|
| hexachlorophene / Chinese Academy of Sciences (0 Trials) |
|
| Hexagen CV (benzalkonium chloride) / Turn Therap (0 Trials) |
|
| Hexalen (altretamine) / Ipsen, Eisai (0 Trials) |
|
| hexameric CD95 ligand (APO010) / Allarity Therap (0 Trials) |
|
| Hexasiil (DTwP–HepB-IPV-Hib) / Serum Institute of India (0 Trials) |
|
| hexasodium phytate (SNF472) / CSL Behring (1 Trials) |
|
| hexavalent DTwP-HepB-Hib-IPV vaccine / Biological E Ltd, GSK (0 Trials) |
|
| Hexaxim (DTaP-IPV-Hep B-Hib vaccine) / Sanofi (4 Trials) |
|
| Hexokinase II inhibitor / vTv Therapeutics (0 Trials) |
|
| Hexopal (inositol nicotinate) / Stada (0 Trials) |
|
| Hextend (6% hetastarch in lactated electrolyte) / Korea Kolmar, Pfizer, Lineage Cell Therap (0 Trials) |
|
| HF 43C5 / Eli Lilly (0 Trials) |
|
| HF-0299 / Newron (0 Trials) |
|
| HF0220 / Newron (0 Trials) |
|
| HFA inhaled nasal steroid (APC-3000) / DMK Pharma (0 Trials) |
|
| HFB 2012 / HiFiBiO (0 Trials) |
|
| HFB1002 / HiFiBiO (0 Trials) |
|
| HFB101110 / FibroGen (0 Trials) |
|
| HFB2-4 / HiFiBiO (0 Trials) |
|
| HFB200301 / HiFiBiO (0 Trials) |
|
| HFB2005 / HiFiBiO (0 Trials) |
|
| HFB200603 / HiFiBiO (0 Trials) |
|
| HFB2008 / HiFiBiO (0 Trials) |
|
| HFB200901 / HiFiBiO, FibroGen (0 Trials) |
|
| HFB200902 / FibroGen (0 Trials) |
|
| HFB301001 / HiFiBiO (0 Trials) |
|
| HG-6-63-01 / University of Naples Federico II (0 Trials) |
|
| HG146 / HitGen (0 Trials) |
|
| HG381 / HitGen (0 Trials) |
|
| HGEN005 / Humanigen (0 Trials) |
|
| hGH-DepoFoam (somatropin) / Pacira (1 Trials) |
|
| HGR4113 / Glaceum (0 Trials) |
|
| HH-003 / Huahui Health (0 Trials) |
|
| HH-006 / Huahui Health (0 Trials) |
|
| HH-009 / Huahui Health (0 Trials) |
|
| HH-018 / Huahui Health (0 Trials) |
|
| HH-101 / Huahui Health (0 Trials) |
|
| HH-120 / Huahui Health (0 Trials) |
|
| HH-30134 / HaiHe Biopharma (0 Trials) |
|
| HH185 / CSPC Pharma, HaiHe Biopharma (0 Trials) |
|
| HH2710 / HaiHe Biopharma (0 Trials) |
|
| HH2853 / HaiHe Biopharma, Shanghai Inst. of Materia Medica (0 Trials) |
|
| HH3806 / HaiHe Biopharma (0 Trials) |
|
| HHT120 / Zhejiang Huahai Pharma (0 Trials) |
|
| HI-164OV / Mariposa Health (0 Trials) |
|
| HI-511 / The Hormel Institute (0 Trials) |
|
| Hi-8 MEL / Oxford Biomedica (0 Trials) |
|
| hI-con1 (ICON-1) / Endpoint Health (0 Trials) |
|
| Hib-DTaP-poliovirus-vaccine / Serum Institute of India (0 Trials) |
|
| HIB210 / HIBio (0 Trials) |
|
| Hibor (bemiparin) / ROVI Pharmaceuticals Laboratories, Elder Pharma (4 Trials) |
|
| HibTITER (diphtheria crm197 protein conjugate) / Nuron Biotech, Mitsubishi Tanabe (0 Trials) |
|
| HiCM-188 / Help Therap (0 Trials) |
|
| high titer convalescent COVID 19 plasma (HT-CCP) / Brigham and Womens Hospital (0 Trials) |
|
| high-activity natural killer cell therapy / HANK Bioengineering (7 Trials) |
|
| high-affinity TCR T cells / BMS (0 Trials) |
|
| high-dose quadrivalent influenza vaccine (GC3114A) / GC Biopharma (0 Trials) |
|
| high-dose tetravalent dengue vaccine (HD-TDV) / Takeda (0 Trials) |
|
| high-titer anti- SARS-CoV-2 plasma / Stanford University (0 Trials) |
|
| high-titer anti-Sars-CoV-2 plasma / Baylor Scott & White Research Institute (0 Trials) |
|
| HIL-214 / Takeda, HilleVax (3 Trials) |
|
| Hillchol (BBV131) / Hilleman Laboratories, Bharat Biotech (0 Trials) |
|
| Hiltonol (poly-ICLC) / Oncovir (43 Trials) |
|
| HinsBet (human insulin) / Adocia (0 Trials) |
|
| HIO inhibitors / Navrogen, Sorrento (0 Trials) |
|
| HIP2101 / Hanmi (0 Trials) |
|
| HIP2105 / Hanmi (0 Trials) |
|
| Hipnos / EMS (0 Trials) |
|
| hiPS-derived T Cells / Minerva Biotech (0 Trials) |
|
| hiPSC-derived neural microtissues / TreeFrog Therap (0 Trials) |
|
| Hirudoid (heparinoid) / Stada (0 Trials) |
|
| HISHS-2001 / Sun Pharma (0 Trials) |
|
| histamine glutarimide (XC-8) / Eurrus Biotech, Valenta Pharm (0 Trials) |
|
| Histimex / Curapel (0 Trials) |
|
| histone deacetylase inhibitors/hypomethylating agents / Jazz (0 Trials) |
|
| histone H1.3 and siRNA apoВ100 (SYN20110119RU) / Pharmsynthez (0 Trials) |
|
| Histone H3.3-K27M Neoantigen Vaccine Therapy / TCRCure (0 Trials) |
|
| hitanercept (T0001) / Shanghai Fudan-Zhangjiang (0 Trials) |
|
| HIV AVC / Cidara Therap (0 Trials) |
|
| HIV E-vaccine / Covalent Biosci (0 Trials) |
|
| HIV MAG pDNA vaccine / Profectus, National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| HIV vaccine / Sanofi (0 Trials) |
|
| HIV vaccine / Gilead, Gritstone bio (0 Trials) |
|
| HIV vaccine vCP1521 / Sanofi (0 Trials) |
|
| HIV vaccine vCP2438 / Sanofi, GSK (0 Trials) |
|
| HIV-1 vaccine / Sunomix (0 Trials) |
|
| HIVconsvX / University of Oxford (0 Trials) |
|
| HIVconsv / IAVI (0 Trials) |
|
| Hivenyl (vapitadine) / GSK (0 Trials) |
|
| HIVirin / Pharmsynthez (0 Trials) |
|
| HIX763 / Novartis (0 Trials) |
|
| Hizentra (human immune globulin subcutaneous 20%) / CSL Behring (5 Trials) |
|
| HJ-N-001 / Tianjin Hengjia Biotech (0 Trials) |
|
| HJC0152 / The University of Texas, UT MD Anderson Cancer Center, Tianjin Medical University Cancer Institute and Hospital (0 Trials) |
|
| HJM-4940 / Protheragen (0 Trials) |
|
| HJM-561 / Jing Medicine (0 Trials) |
|
| HK-001 / Everfront Biotech (0 Trials) |
|
| HK013 / HankeMab (0 Trials) |
|
| HKI-357 / Pfizer (0 Trials) |
|
| HKT288 / MorphoSys, Novartis (0 Trials) |
|
| HL144 / Daewoong Pharma (0 Trials) |
|
| HL1513 (IMD) / Handok (0 Trials) |
|
| HL186 / Daewoong Pharma (0 Trials) |
|
| HL187 / Daewoong Pharma (0 Trials) |
|
| HL231 / Haisco (0 Trials) |
|
| HL2351 / Handok, Genexine (0 Trials) |
|
| HL2353 / Handok (0 Trials) |
|
|